However, since the genetic interactions of hsa-miR-183-5p-BTNL9, hsa-miR-33b-5p-CPED1, hsa-miR-429-CPED1, hsa-miR-182-5p-FMO2, hsa-miR-130b-5p-IL33, and hsa-miR-542-3p-IL33 have not been identified, these altered genetic regulations may play important roles in the progression of lung adenocarcinoma. This evidence concerns the gene BTNL9 and lung adenocarcinoma.